Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 11005
Gene Symbol: SPINK5
SPINK5
1.000 GermlineCausalMutation disease ORPHANET Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. 10835624 2000
Entrez Id: 11005
Gene Symbol: SPINK5
SPINK5
1.000 GeneticVariation disease BEFREE We describe here eleven different mutations in SPINK5, encoding the serine protease inhibitor LEKTI, in 13 families with Netherton syndrome (NS, MIM256500). 10835624 2000
Entrez Id: 3383
Gene Symbol: ICAM1
ICAM1
0.010 AlteredExpression disease BEFREE Reduced hepatic injury after HTS and I/R was accompanied by inhibition of I/R-induced hepatic ICAM-1 mRNA expression compared to NS treated animals (P < 0.01). 11028565 2000
Entrez Id: 2316
Gene Symbol: FLNA
FLNA
0.010 Biomarker disease BEFREE There were three major new findings: (a) long term (>5 years) occupational exposure to cold and draught was associated with a significantly increased prevalence of chronic bronchitis; compared with others, and adjusted for confounders, the odds ratio (OR) with 95% confidence interval (95% CI) was 1.4 (1.1 to 1.7), p=0.004; (b) a significant J shaped association existed between alcohol use and bronchitis, p<0.001, with the lowest prevalence found among moderate users; (c) a significant gene by environment association existed between smoking and the NS-phenotype in the MNS blood group; only among smokers was the NS-phenotype associated with a significantly decreased risk of chronic bronchitis, OR 0.67 (0.47-0.97), p=0.02. 11171928 2001
Entrez Id: 2993
Gene Symbol: GYPA
GYPA
0.010 Biomarker disease BEFREE There were three major new findings: (a) long term (>5 years) occupational exposure to cold and draught was associated with a significantly increased prevalence of chronic bronchitis; compared with others, and adjusted for confounders, the odds ratio (OR) with 95% confidence interval (95% CI) was 1.4 (1.1 to 1.7), p=0.004; (b) a significant J shaped association existed between alcohol use and bronchitis, p<0.001, with the lowest prevalence found among moderate users; (c) a significant gene by environment association existed between smoking and the NS-phenotype in the MNS blood group; only among smokers was the NS-phenotype associated with a significantly decreased risk of chronic bronchitis, OR 0.67 (0.47-0.97), p=0.02. 11171928 2001
Entrez Id: 2996
Gene Symbol: GYPE
GYPE
0.010 Biomarker disease BEFREE There were three major new findings: (a) long term (>5 years) occupational exposure to cold and draught was associated with a significantly increased prevalence of chronic bronchitis; compared with others, and adjusted for confounders, the odds ratio (OR) with 95% confidence interval (95% CI) was 1.4 (1.1 to 1.7), p=0.004; (b) a significant J shaped association existed between alcohol use and bronchitis, p<0.001, with the lowest prevalence found among moderate users; (c) a significant gene by environment association existed between smoking and the NS-phenotype in the MNS blood group; only among smokers was the NS-phenotype associated with a significantly decreased risk of chronic bronchitis, OR 0.67 (0.47-0.97), p=0.02. 11171928 2001
Entrez Id: 2994
Gene Symbol: GYPB
GYPB
0.010 Biomarker disease BEFREE There were three major new findings: (a) long term (>5 years) occupational exposure to cold and draught was associated with a significantly increased prevalence of chronic bronchitis; compared with others, and adjusted for confounders, the odds ratio (OR) with 95% confidence interval (95% CI) was 1.4 (1.1 to 1.7), p=0.004; (b) a significant J shaped association existed between alcohol use and bronchitis, p<0.001, with the lowest prevalence found among moderate users; (c) a significant gene by environment association existed between smoking and the NS-phenotype in the MNS blood group; only among smokers was the NS-phenotype associated with a significantly decreased risk of chronic bronchitis, OR 0.67 (0.47-0.97), p=0.02. 11171928 2001
Entrez Id: 11005
Gene Symbol: SPINK5
SPINK5
1.000 GeneticVariation disease CLINVAR The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis. 11511292 2001
Entrez Id: 11005
Gene Symbol: SPINK5
SPINK5
1.000 CausalMutation disease CLINVAR The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis. 11511292 2001
Entrez Id: 11005
Gene Symbol: SPINK5
SPINK5
1.000 GeneticVariation disease BEFREE Recently, recessive mutations in SPINK5 were identified in several Comèl-Netherton syndrome patients from consanguineous families. 11511292 2001
Entrez Id: 11005
Gene Symbol: SPINK5
SPINK5
1.000 GeneticVariation disease CLINVAR Recently, we identified SPINK5, which encodes the serine protease inhibitor Kazal-type 5 protein (LEKTI), as the defective gene in Netherton syndrome. 11841556 2002
Entrez Id: 11005
Gene Symbol: SPINK5
SPINK5
1.000 CausalMutation disease CLINVAR Recently, we identified SPINK5, which encodes the serine protease inhibitor Kazal-type 5 protein (LEKTI), as the defective gene in Netherton syndrome. 11841556 2002
Entrez Id: 11005
Gene Symbol: SPINK5
SPINK5
1.000 Biomarker disease GENOMICS_ENGLAND Recently, we identified SPINK5, which encodes the serine protease inhibitor Kazal-type 5 protein (LEKTI), as the defective gene in Netherton syndrome. 11841556 2002
Entrez Id: 11005
Gene Symbol: SPINK5
SPINK5
1.000 Biomarker disease BEFREE Recently, we identified SPINK5, which encodes the serine protease inhibitor Kazal-type 5 protein (LEKTI), as the defective gene in Netherton syndrome. 11841556 2002
Entrez Id: 11005
Gene Symbol: SPINK5
SPINK5
1.000 GeneticVariation disease BEFREE Direct SPINK5 mutation analysis in families at risk for NS represents the first early, rapid and reliable method for prenatal diagnosis of this life threatening form of ichthyosis. 11857617 2002
Entrez Id: 11005
Gene Symbol: SPINK5
SPINK5
1.000 GeneticVariation disease BEFREE The findings in this study suggest that the defective inhibitory regulation of desquamation due to the serine protease inhibitor Kazal-type 5 gene mutations may cause over-desquamation of corneocytes in Netherton syndrome, leading to severe skin permeability barrier dysfunction. 11874482 2002
Entrez Id: 11005
Gene Symbol: SPINK5
SPINK5
1.000 GeneticVariation disease BEFREE Recent results of another group show a relation between mutations within the LEKTI gene and the severe congenital disorder Netherton syndrome. 11943586 2002
Entrez Id: 28471
Gene Symbol: IGHV1-12
IGHV1-12
0.010 Biomarker disease BEFREE Heterogeneity in the copy number of i(12p) and other 12p-derived markers, as well as chromosome 12 aneuploidy, were higher in NS tumors than in SE. 12034520 2002
Entrez Id: 1234
Gene Symbol: CCR5
CCR5
0.010 GeneticVariation disease BEFREE The frequency of the CCR5-Delta32 allele was higher in the anti-HCV(+) (16.0%, P < 0.05) and anti-HCV(+)/HIV(+) (12.7%, NS) patients than in healthy blood donors (8.3%) and anti-HIV(+) patients (9.3%), respectively. 12055576 2002
Entrez Id: 11005
Gene Symbol: SPINK5
SPINK5
1.000 AlteredExpression disease BEFREE Defective expression of LEKTI in skin sections was a constant feature in NS patients, whilst an extended reactivity pattern was observed in samples from other keratinizing disorders, demonstrating that loss of LEKTI expression in the epidermis is a diagnostic feature of NS. 12915442 2003
Entrez Id: 11005
Gene Symbol: SPINK5
SPINK5
1.000 GeneticVariation disease BEFREE A compound heterozygous mutation of the SPINK5 gene in a Taiwanese boy with Netherton syndrome. 12923596 2003
Entrez Id: 11005
Gene Symbol: SPINK5
SPINK5
1.000 GeneticVariation disease BEFREE Mutations in the gene encoding serine protease inhibitor Kazal-type 5 (SPINK5) are responsible for Netherton syndrome, a rare skin disorder characterized by greatly elevated IgE levels with atopic manifestations. 14551605 2003
Entrez Id: 11005
Gene Symbol: SPINK5
SPINK5
1.000 Biomarker disease BEFREE Sequence analyses of SPINK5 in seven NTS patients from five different families allowed us to identify two known and three novel mutations all creating premature termination codons. 15304086 2004
Entrez Id: 1673
Gene Symbol: DEFB4A
DEFB4A
0.010 AlteredExpression disease BEFREE Moreover, comparable with the altered pattern in psoriatic skin the epidermis in NTS strongly expressed the serine proteinase inhibitor SKALP/elafin and the anti-microbial protein human beta-defensin 2. 15304086 2004
Entrez Id: 5266
Gene Symbol: PI3
PI3
0.010 AlteredExpression disease BEFREE Moreover, comparable with the altered pattern in psoriatic skin the epidermis in NTS strongly expressed the serine proteinase inhibitor SKALP/elafin and the anti-microbial protein human beta-defensin 2. 15304086 2004